579 related articles for article (PubMed ID: 11774951)
21. Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment.
Cheng Y; Freeden C; Zhang Y; Abraham P; Shen H; Wescott D; Humphreys WG; Gan J; Lai Y
Biopharm Drug Dispos; 2016 Jul; 37(5):276-86. PubMed ID: 27059119
[TBL] [Abstract][Full Text] [Related]
22. Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver.
Dombrowski F; Stieger B; Beuers U
Lab Invest; 2006 Feb; 86(2):166-74. PubMed ID: 16344857
[TBL] [Abstract][Full Text] [Related]
23. Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis.
Kojima H; Nies AT; König J; Hagmann W; Spring H; Uemura M; Fukui H; Keppler D
J Hepatol; 2003 Nov; 39(5):693-702. PubMed ID: 14568249
[TBL] [Abstract][Full Text] [Related]
24. Effects of High-cholesterol Diet on Pravastatin Disposition in the Perfused Rat Liver.
Kawase A; Handa A; Iwaki M
Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):519-526. PubMed ID: 27511381
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms involved in spironolactone-induced choleresis in the rat. Role of multidrug resistance-associated protein 2.
Ruiz ML; Villanueva SS; Luquita MG; Sánchez-Pozzi EJ; Crocenzi FA; Pellegrino JM; Ochoa JE; Vore M; Mottino AD; Catania VA
Biochem Pharmacol; 2005 Feb; 69(3):531-9. PubMed ID: 15652244
[TBL] [Abstract][Full Text] [Related]
26. Hepatobiliary transport of bile acids and organic anions.
Takikawa H
J Hepatobiliary Pancreat Surg; 2002; 9(4):443-7. PubMed ID: 12483266
[TBL] [Abstract][Full Text] [Related]
27. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats.
Vos TA; Ros JE; Havinga R; Moshage H; Kuipers F; Jansen PL; Müller M
Hepatology; 1999 Jun; 29(6):1833-9. PubMed ID: 10347127
[TBL] [Abstract][Full Text] [Related]
28. Cholestasis and the role of basolateral efflux pumps.
Keppler D
Z Gastroenterol; 2011 Jul; 49(12):1553-7. PubMed ID: 22139880
[TBL] [Abstract][Full Text] [Related]
29. Hepatic gene transfer of human aquaporin-1 improves bile salt secretory failure in rats with estrogen-induced cholestasis.
Marrone J; Soria LR; Danielli M; Lehmann GL; Larocca MC; Marinelli RA
Hepatology; 2016 Aug; 64(2):535-48. PubMed ID: 26999313
[TBL] [Abstract][Full Text] [Related]
30. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver.
Shoda J; Miura T; Utsunomiya H; Oda K; Yamamoto M; Kano M; Ikegami T; Tanaka N; Akita H; Ito K; Suzuki H; Sugiyama Y
Hepatology; 2004 Jan; 39(1):167-78. PubMed ID: 14752835
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.
Köck K; Ferslew BC; Netterberg I; Yang K; Urban TJ; Swaan PW; Stewart PW; Brouwer KL
Drug Metab Dispos; 2014 Apr; 42(4):665-74. PubMed ID: 24154606
[TBL] [Abstract][Full Text] [Related]
32. High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease.
Ros JE; Libbrecht L; Geuken M; Jansen PL; Roskams TA
J Pathol; 2003 Aug; 200(5):553-60. PubMed ID: 12898590
[TBL] [Abstract][Full Text] [Related]
33. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
Funk C; Ponelle C; Scheuermann G; Pantze M
Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
[TBL] [Abstract][Full Text] [Related]
34. Hepatic transport of bile salts.
Kullak-Ublick GA; Stieger B; Hagenbuch B; Meier PJ
Semin Liver Dis; 2000; 20(3):273-92. PubMed ID: 11076396
[TBL] [Abstract][Full Text] [Related]
35. Taurine supplementation induces multidrug resistance protein 2 and bile salt export pump expression in rats and prevents endotoxin-induced cholestasis.
Mühlfeld A; Kubitz R; Dransfeld O; Häussinger D; Wettstein M
Arch Biochem Biophys; 2003 May; 413(1):32-40. PubMed ID: 12706339
[TBL] [Abstract][Full Text] [Related]
36. [New molecular features of cholestatic diseases of the liver].
Méndez-Sánchez N; Chavez-Tapia NC; Uribe M
Rev Invest Clin; 2003; 55(5):546-56. PubMed ID: 14968476
[TBL] [Abstract][Full Text] [Related]
37. Altered expression and function of canalicular transporters during early development of cholestatic liver injury in Abcb4-deficient mice.
Cai SY; Mennone A; Soroka CJ; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(8):G670-6. PubMed ID: 24481602
[TBL] [Abstract][Full Text] [Related]
38. Sustained intrahepatic glutathione depletion causes proteasomal degradation of multidrug resistance-associated protein 2 in rat liver.
Sekine S; Mitsuki K; Ito K; Kugioka S; Horie T
Biochim Biophys Acta; 2012 Jun; 1822(6):980-7. PubMed ID: 22330094
[TBL] [Abstract][Full Text] [Related]
39. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.
Beuers U; Bilzer M; Chittattu A; Kullak-Ublick GA; Keppler D; Paumgartner G; Dombrowski F
Hepatology; 2001 May; 33(5):1206-16. PubMed ID: 11343250
[TBL] [Abstract][Full Text] [Related]
40. Disturbed colocalization of multidrug resistance protein 2 and radixin in human cholestatic liver diseases.
Kojima H; Sakurai S; Uemura M; Kitamura K; Kanno H; Nakai Y; Fukui H
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e120-8. PubMed ID: 17725603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
